Analystreport

Aptevo Therapeutics Inc. (NASDAQ: APVO) was downgraded by analysts at UBS Group AG from a "buy" rating to a "neutral" rating.

Aptevo Therapeutics Inc.  (APVO) 
Last aptevo therapeutics inc. earnings: 8/9 09:00 am Check Earnings Report
US:NASDAQ Investor Relations: ir.aptevotherapeutics.com/investor-overview